 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Ratcliffe Liam
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2016-10-25 Purchase | 2016-10-25 1:22 pm | iRhythm Technologies Inc. | IRTC | New Leaf Ventures II L.P. Delagardelle Jeani HUNT RONALD Ratcliffe Liam New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. Chambon Philippe O. 10% Owner | 25,000 | $17 | $425,000 | 1,741,589 (Direct) | View |
| 2017-10-02 Purchase | 2017-10-02 4:40 pm | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 375,000 | $17 | $6,375,000 | 2,146,308 (Indirect) | View |
| 2018-04-03 Purchase | 2018-04-03 4:30 pm | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 550,000 | $12 | $6,600,000 | 897,773 (Indirect) | View |
| 2018-05-30 Purchase | 2018-05-31 4:54 pm | Iterum Therapeutics plc | ITRM | Lathi Vijay K Ratcliffe Liam 10% Owner | 662,677 | $13 | $8,614,801 | 384,615 (Indirect) | View |
| 2018-06-25 Purchase | 2018-06-26 4:53 pm | Aptinyx Inc. | APTX | Ratcliffe Liam Director 10% Owner | 250,000 | $16 | $4,000,000 | 368,345 (Indirect) | View |
| 2018-10-01 Purchase | 2018-10-03 5:22 pm | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 1,000,000 | $16 | $16,000,000 | 375,000 (Indirect) | View |
| 2019-11-12 Purchase | 2019-11-14 4:23 pm | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 680,000 | $22 | $14,960,000 | 680,000 (Indirect) | View |
| 2020-03-03 Purchase | 2020-03-03 6:48 pm | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 2,800 | $18 | $50,400 | 2,800 (Direct) | View |
| 2020-03-03 Purchase(A) | 2020-03-13 5:20 pm | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 552,800 | $18 | $9,950,400 | 2,800 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2016-06-21 Option Award | 2016-06-23 9:24 pm | 2017-06-21 2026-06-21 | Edge Therapeutics Inc. | EDGE | Ratcliffe Liam New Leaf Venture Partners L.L.C. Director | 30,000 | $9.34 | 30,000 (Direct) | View |
| 2016-10-25 Conversion | 2016-10-25 1:22 pm | N/A N/A | iRhythm Technologies Inc. | IRTC | New Leaf Ventures II L.P. Delagardelle Jeani HUNT RONALD Ratcliffe Liam New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. Chambon Philippe O. 10% Owner | 1,716,589 | $0 | 1,741,589 (Direct) | View |
| 2016-10-25 Conversion | 2016-10-25 1:22 pm | N/A N/A | iRhythm Technologies Inc. | IRTC | New Leaf Ventures II L.P. Delagardelle Jeani HUNT RONALD Ratcliffe Liam New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. Chambon Philippe O. 10% Owner | 610,136 | $0 | 1,741,589 (Direct) | View |
| 2016-10-25 Conversion | 2016-10-25 1:22 pm | N/A N/A | iRhythm Technologies Inc. | IRTC | New Leaf Ventures II L.P. Delagardelle Jeani HUNT RONALD Ratcliffe Liam New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. Chambon Philippe O. 10% Owner | 190,154 | $0 | 1,741,589 (Direct) | View |
| 2016-10-25 Conversion | 2016-10-25 1:22 pm | N/A N/A | iRhythm Technologies Inc. | IRTC | New Leaf Ventures II L.P. Delagardelle Jeani HUNT RONALD Ratcliffe Liam New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. Chambon Philippe O. 10% Owner | 155,548 | $0 | 1,741,589 (Direct) | View |
| 2016-10-25 Conversion | 2016-10-25 1:22 pm | 2012-11-01 2019-11-01 | iRhythm Technologies Inc. | IRTC | New Leaf Ventures II L.P. Delagardelle Jeani HUNT RONALD Ratcliffe Liam New Leaf Venture Associates II L.P. New Leaf Venture Management II L.L.C. Chambon Philippe O. 10% Owner | 72,389 | $0.001 | 1,741,589 (Direct) | View |
| 2017-06-20 Option Award | 2017-06-21 2:19 pm | 2018-06-20 2027-06-20 | Edge Therapeutics Inc. | EDGE | Ratcliffe Liam Director | 15,000 | $10.15 | 15,000 (Direct) | View |
| 2017-10-02 Conversion | 2017-10-02 4:40 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 839,110 | $0 | 2,146,308 (Indirect) | View |
| 2017-10-02 Conversion | 2017-10-02 4:40 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 1,118,722 | $0 | 2,146,308 (Indirect) | View |
| 2017-10-02 Conversion | 2017-10-02 4:40 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 279,703 | $0 | 2,146,308 (Indirect) | View |
| 2017-10-02 Conversion | 2017-10-02 4:40 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 1,118,722 | $0 | 2,146,308 (Indirect) | View |
| 2017-10-02 Conversion | 2017-10-02 4:40 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 372,883 | $0 | 2,146,308 (Indirect) | View |
| 2017-10-02 Conversion | 2017-10-02 4:40 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 148,515 | $0 | 2,146,308 (Indirect) | View |
| 2017-10-02 Conversion | 2017-10-02 4:40 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 198,004 | $0 | 2,146,308 (Indirect) | View |
| 2017-10-02 Conversion | 2017-10-02 4:40 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 49,505 | $0 | 2,146,308 (Indirect) | View |
| 2017-10-02 Conversion | 2017-10-02 4:40 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 198,004 | $0 | 2,146,308 (Indirect) | View |
| 2017-10-02 Conversion | 2017-10-02 4:40 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 65,997 | $0 | 2,146,308 (Indirect) | View |
| 2018-04-03 Conversion | 2018-04-03 4:30 pm | N/A N/A | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 622,772 | $0 | 897,773 (Indirect) | View |
| 2018-04-03 Conversion | 2018-04-03 4:30 pm | N/A N/A | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 622,773 | $0 | 897,773 (Indirect) | View |
| 2018-04-03 Conversion | 2018-04-03 4:30 pm | N/A N/A | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 977,835 | $0 | 897,773 (Indirect) | View |
| 2018-04-03 Conversion | 2018-04-03 4:30 pm | N/A N/A | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 977,836 | $0 | 897,773 (Indirect) | View |
| 2018-05-17 Option Award | 2018-05-21 4:25 pm | N/A 2028-05-16 | Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director 10% Owner | 12,000 | $25.73 | 12,000 (Direct) | View |
| 2018-05-30 Conversion | 2018-05-31 4:54 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Lathi Vijay K Ratcliffe Liam 10% Owner | 466,793 | $0 | 384,615 (Indirect) | View |
| 2018-05-30 Conversion | 2018-05-31 4:54 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Lathi Vijay K Ratcliffe Liam 10% Owner | 178,230 | $0 | 384,615 (Indirect) | View |
| 2018-05-30 Conversion | 2018-05-31 4:54 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Lathi Vijay K Ratcliffe Liam 10% Owner | 148,603 | $0 | 384,615 (Indirect) | View |
| 2018-05-30 Conversion | 2018-05-31 4:54 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Lathi Vijay K Ratcliffe Liam 10% Owner | 466,793 | $0 | 384,615 (Indirect) | View |
| 2018-05-30 Conversion | 2018-05-31 4:54 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Lathi Vijay K Ratcliffe Liam 10% Owner | 178,230 | $0 | 384,615 (Indirect) | View |
| 2018-05-30 Conversion | 2018-05-31 4:54 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Lathi Vijay K Ratcliffe Liam 10% Owner | 148,603 | $0 | 384,615 (Indirect) | View |
| 2018-06-19 Option Award | 2018-06-20 4:54 pm | N/A N/A | Edge Therapeutics Inc. | EDGE | Ratcliffe Liam Director | 20,000 | $1.1 | 20,000 (Direct) | View |
| 2018-06-25 Conversion | 2018-06-26 4:53 pm | N/A N/A | Aptinyx Inc. | APTX | Ratcliffe Liam Director 10% Owner | 1,047,450 | $0 | 368,345 (Indirect) | View |
| 2018-06-25 Conversion | 2018-06-26 4:53 pm | N/A N/A | Aptinyx Inc. | APTX | Ratcliffe Liam Director 10% Owner | 1,197,076 | $0 | 368,345 (Indirect) | View |
| 2018-06-25 Conversion | 2018-06-26 4:53 pm | N/A N/A | Aptinyx Inc. | APTX | Ratcliffe Liam Director 10% Owner | 552,208 | $0 | 368,345 (Indirect) | View |
| 2018-06-25 Conversion | 2018-06-26 4:53 pm | N/A N/A | Aptinyx Inc. | APTX | Ratcliffe Liam Director 10% Owner | 243,345 | $0 | 368,345 (Indirect) | View |
| 2018-06-25 Conversion | 2018-06-26 4:53 pm | N/A N/A | Aptinyx Inc. | APTX | Ratcliffe Liam Director 10% Owner | 28,895,188 | $0 | 368,345 (Indirect) | View |
| 2018-06-25 Conversion | 2018-06-26 4:53 pm | N/A N/A | Aptinyx Inc. | APTX | Ratcliffe Liam Director 10% Owner | 33,022,786 | $0 | 368,345 (Indirect) | View |
| 2018-06-25 Conversion | 2018-06-26 4:53 pm | N/A N/A | Aptinyx Inc. | APTX | Ratcliffe Liam Director 10% Owner | 15,233,315 | $0 | 368,345 (Indirect) | View |
| 2018-06-25 Conversion | 2018-06-26 4:53 pm | N/A N/A | Aptinyx Inc. | APTX | Ratcliffe Liam Director 10% Owner | 6,712,986 | $0 | 368,345 (Indirect) | View |
| 2018-08-14 Option Award | 2018-08-15 08:05 am | N/A N/A | Edge Therapeutics Inc. | EDGE | Ratcliffe Liam Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2018-07-26 Option Award | 2018-09-26 6:47 pm | N/A 2028-07-26 | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 1,504 | $8.72 | 1,504 (Direct) | View |
| 2018-10-01 Option Award | 2018-10-03 5:19 pm | N/A 2028-10-01 | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 2,111 | $6.22 | 2,111 (Direct) | View |
| 2018-10-01 Conversion | 2018-10-03 5:22 pm | N/A N/A | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 1,108,202 | $0 | 375,000 (Indirect) | View |
| 2018-10-01 Conversion | 2018-10-03 5:22 pm | N/A N/A | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 174,846 | $0 | 375,000 (Indirect) | View |
| 2018-10-01 Conversion | 2018-10-03 5:22 pm | N/A N/A | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 3,601,657 | $0 | 375,000 (Indirect) | View |
| 2018-10-01 Conversion | 2018-10-03 5:22 pm | N/A N/A | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 568,252 | $0 | 375,000 (Indirect) | View |
| 2019-01-02 Option Award | 2019-01-04 4:57 pm | N/A 2029-01-02 | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 4,860 | $2.7 | 4,860 (Direct) | View |
| 2019-03-15 Exercise | 2019-03-18 5:52 pm | N/A N/A | Edge Therapeutics Inc. | EDGE | Ratcliffe Liam Director | 10,000 | $0 | 0 (Direct) | View |
| 2019-03-15 Exercise | 2019-03-18 5:52 pm | N/A N/A | Edge Therapeutics Inc. | EDGE | Ratcliffe Liam Director | 10,000 | $0 | 0 (Direct) | View |
| 2019-03-29 Option Award | 2019-04-02 4:24 pm | N/A 2029-03-28 | Aptinyx Inc. | APTX | Ratcliffe Liam Director | 4,123 | $2.425 | 4,123 (Direct) | View |
| 2019-04-01 Option Award | 2019-04-03 4:32 pm | N/A 2029-04-01 | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 4,829 | $2.7185 | 4,829 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 5:11 pm | N/A 2029-05-22 | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 12,923 | $22.06 | 12,923 (Direct) | View |
| 2019-06-14 Option Award | 2019-06-18 4:27 pm | N/A 2029-06-14 | Unum Therapeutics Inc. | UMRX | Ratcliffe Liam Director | 7,881 | $1.6654 | 7,881 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 5:58 pm | N/A 2030-02-27 | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 33,836 | $18 | 33,836 (Direct) | View |
| 2020-03-03 Conversion | 2020-03-13 5:20 pm | N/A N/A | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 2,066,630 | $0 | 2,800 (Indirect) | View |
| 2020-03-03 Conversion | 2020-03-13 5:20 pm | N/A N/A | Passage BIO Inc. | PASG | Ratcliffe Liam Director | 2,066,630 | $0 | 2,800 (Indirect) | View |
| 2020-05-26 Exercise | 2020-05-27 6:34 pm | N/A N/A | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 6,500 | $22.06 | 6,423 (Direct) | View |
| 2020-05-26 Exercise | 2020-05-27 6:34 pm | N/A 2029-05-22 | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 6,500 | $22.06 | 6,423 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-04 9:00 pm | N/A 2030-06-02 | ARVINAS Inc | ARVN | Ratcliffe Liam Director | 12,000 | $33.57 | 12,000 (Direct) | View |